Tactile Systems Technolog...

14.08
-0.21 (-1.47%)
At close: Mar 03, 2025, 3:59 PM
13.82
-1.82%
After-hours: Mar 03, 2025, 04:02 PM EST

Company Description

Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States.

The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders.

The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

Tactile Systems Technology Inc.
Tactile Systems Technology Inc. logo
Country United States
IPO Date Jul 28, 2016
Industry Medical - Devices
Sector Healthcare
Employees 1,037
CEO Sheri Louise Dodd

Contact Details

Address:
3701 Wayzata Boulevard
Minneapolis, Minnesota
United States
Website https://www.tactilemedical.com

Stock Details

Ticker Symbol TCMD
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001027838
CUSIP Number 87357P100
ISIN Number US87357P1003
Employer ID 00-0000000
SIC Code 3841

Key Executives

Name Position
Sheri Louise Dodd Chief Executive Officer, President & Director
Elaine M. Birkemeyer Chief Financial Officer
John David Kaercher Chief Information Officer
Aaron R. Snodgrass Senior Vice President of Sales
Daniel L. Reuvers Director & Advisor
Dr. Antonios P. Gasparis F.A.C.S., M.D. Chief Medical Officer & Member of Vascular Strategic Advisory Board
Janelle M. Strop Chief Human Resource Officer
Jerry A. Sauber Senior Vice President of Manufacturing, Operations, R&D
Kristie T. Burns Senior Vice President of Marketing & Clinical Affairs
Sunday J. Hoy Esq. Vice President of Regulatory Affairs & Chief Compliance Officer

Latest SEC Filings

Date Type Title
Feb 27, 2025 4 Filing
Feb 27, 2025 4 Filing
Feb 27, 2025 4 Filing
Feb 24, 2025 4 Filing
Feb 24, 2025 4 Filing
Feb 24, 2025 4 Filing
Feb 24, 2025 4 Filing
Feb 24, 2025 4 Filing
Feb 18, 2025 S-8 Filing
Feb 18, 2025 10-K Annual Report